Name: A shrimp seller in Wuhan identified as 'patient 0'
Uploaded: 2020-03-29T11:17:56.0+05:30
Duration: T00M47S
Channel: editorji

A 57-year-old female shrimp seller in China's Wuhan city, has been identified as one of the first victims of Covid-19, according to reports. Wei Guixian, was selling sh

A shrimp seller in Wuhan identified as 'patient 0'

A 57-year-old female shrimp seller in China's Wuhan city, has been identified as one of the first victims of Covid-19, according to reports. Wei Guixian, was selling shrimps at the Huanan Seafood Market on December 10 when she first developed a cold. Believing she had the common flu, she went to a local clinic for treatment where she was given an injection and let go. Feeling weak and lethargic, the woman visited another hospital on 16th December, when she was told her sickness and ruthless and was put in quarantine. The coronavirus 'patient zero', who made a full recovery in January after month-long treatment, believes the Chinese government could have checked the spread of the disease had it acted sooner.

A 57-year-old female shrimp seller in China's Wuhan city, has been identified as one of the first victims of Covid-19, according to reports. Wei Guixian, was selling shrimps at the Huanan Seafood Market on December 10 when she first developed a cold. Believing she had the common flu, she went to a local clinic for treatment where she was given an injection and let go. Feeling weak and lethargic, the woman visited another hospital on 16th December, when she was told her sickness and ruthless and was put in quarantine. The coronavirus 'patient zero', who made a full recovery in January after month-long treatment, believes the Chinese government could have checked the spread of the disease had it acted sooner.

Residents of a housing society in Mumbai claim they were the victims of an elaborate “vaccination scam”, in which they were given fake Covid-19 shots. At R

Residents of a posh housing society in Mumbai&nbsp;have allege that they have been victims of a &ldquo;vaccination scam&rdquo;. They fear they have been given fake Covid-19 shots.
At ₹1260 per dose, 390 people received the shots as part of a vaccination camp at Hiranandani Estate Society in Kandivali on May 30. The society paid around ₹5 lakh to the facilitator.
Suspicions arose when none of the inoculated persons developed any usual post-jab symptoms. The beneficiaries received their certificates 10-15 days later from different hospitals like Nanavati, Lifeline, Nesco BMC vaccination centre etc. However, when contacted, these hospitals denied providing vaccines to the housing society in question.
The incident has sparked anxiety among the residents of Hiranandani Estate, who are wondering if the shots were genuine.

The decision regarding enhancing interval between two doses of Covishield was based on scientific evidence and taken in a transparent manner, a key govt panel said on T

The decision regarding enhancing interval between two doses of Covishield was based on scientific evidence and taken in a transparent manner, health minister Harsh Vardhan said on Wednesday. He added that it is unfortunate that such a crucial matter is being politicised.&nbsp;
On Tuesday, the National Technical Advisory Group on Immunization head Dr N K Arora&nbsp;had also clarified that the decision was transparent and unanimous.&nbsp;
The govt's clarification came after some reports claimed that scientists didn't agree with enhancing the gap. A Reuters report quoted a former director of the National Institute of Epidemiology, MD Gupte, who claimed that the government's expert panel did not agree to increase the gap to 12 to 16 weeks at one leap.
The government had on May 13 extended the gap between the two doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks.

Coronavirus News: India reported 62,224 new cases of the coronavirus and 2,542 related fatalities in the last 24 hours, according to the health ministry.

India reported 62,224 new cases of the <a href="https://www.editorji.com/covid-19" target="_blank">coronavirus</a> and 2,542 related fatalities in the last 24 hours, according to the health ministry dashboard on Wednesday morning. The spike took the country's caseload to 2.96 crore and death toll to 3.79 lakh.
This is the ninth consecutive day that the daily cases remained below the 1 lakh-mark. The active cases have come down to 8.6 lakh and now constitute 3 per cent of the caseload.
The daily positivity rate has further dropped to 3.22 per cent. It for the ninth straight day that India is seeing a positivity rate below 5 per cent.
Also Read | <a href="https://www.editorji.com/story/covid-19-delta-plus-variant-of-interest-not-variant-of-concern-says-centre-1623773975459" target="_blank">Covid-19: Delta plus 'variant of interest' not 'variant of concern', says Centre</a>

As more evidence poured in of the second shots being crucial for adequate protection, there is a rethink in the govt on the gap between two doses of Covishield, which w

As more evidence poured in of the second shots being crucial for adequate protection, there is a rethink in the govt on the gap between two doses of Covishield, which was increased to 12 weeks. The Hindustan Times has reported that govt experts have held meeting to review the gap and are considering reducing it, especially for those with comorbidities.
The rethink has come after UK released fresh data showing protection from hospitalisation was 92% for people who had both doses of the Oxford-AstraZeneca vaccine. Covishield is the made-in-India version of the dose. Those who had just one dose showed a much lower efficacy against hospitalisation at 71%. The UK has already reduced the gap between doses for those over the age of 40 to eight weeks.

CBSE class XII students are likely to have their results based on their performance in the finals of class X and XI exams and class XII pre-board tests. The Times of I

CBSE class XII students are likely to have their results based on their performance in the finals of class X and XI exams and class XII pre-board tests.
The Times of India has reported that the CBSE-appointed committee to recommend the criteria to evaluate Class XII students seems to be in favour of a 30:30:40 formula. Which means 30% weightage will be given to class X and XI final results, respectively, and 40% to class XII pre-board exams.
The committee is expected to announce the marking formula after submitting it to the Supreme Court on Thursday.
Principals have told the committee that they are in a position to mark students based on tests and exams conducted in schools during the academic year 2020-21, the report added.
CBSE cancelled Class XII exams on June 1 due to the Covid second wave.
&nbsp;

To pace up Covid vaccination, the government has now opened walk-in vaccination for all adults. Anyone over the age of 18 can walk in to the nearest vaccination centre

To pace up Covid vaccination, the government has now opened walk-in vaccination for all adults. Anyone over the age of 18 can walk in to the nearest vaccination centre to get registered on the CoWIN digital platform and be inoculated against Covid-19, the Health Ministry has said.
It is not mandatory to pre-register online or book an appointment to get the vaccine, the government said. The govt had last month said that people in the 18-44 age group - who are "without access to internet or smart phones" - can walk-in for help to register on the CoWIN digital platform, and get appointments to be vaccinated against Covid-19.
Vaccinating people in the 18-44 age group - the country's largest demographic - is key to fight the pandemic and lift restrictions.

The government said on Tuesday that the new Delta Plus mutation of coronavirus is "a variant of interest", not "a variant of concern". NITI Aayog's Member Health, Dr V

The government said on Tuesday that the new Delta Plus mutation of coronavirus is "a variant of interest", not "a variant of concern".
NITI Aayog's Member Health, Dr V.K. Paul, said at a Health Ministry press meet that&nbsp;Delta variant played a major role in the second wave and an additional mutation of this variant, known as Delta Plus, has been detected and submitted to the global data system. He said it has been seen in Europe since March and was brought into the public domain two days ago on June 13.&nbsp;
He said as per data available in the public domain, this variant nullifies the use of monoclonal antibody and the government will will scientifically study and learn more about this variant.
&nbsp;

The Union ministry of health and family welfare on Tuesday dismissed reports that claimed that a high number of deaths following vaccination Covid-19 are taking place a

The Union ministry of health and family welfare on Tuesday dismissed reports that claimed that a high number of deaths following vaccination Covid-19 are taking place and these are linked to post-Covid complications. These reports, according to the ministry, were based on "incomplete and limited understanding" of the process. &nbsp;As per the media reports, 488 deaths following vaccination are linked to post-Covid complications during 16th Jan 2021 and 7th June 2021 period where the total vaccination coverage was 23.5 crore.&nbsp;

The Union Health Ministry on Tuesday said that an 85 per cent decline in daily Covid-19 cases has been noted since the highest reported peak on May 7. Lav Aga

The Union Health Ministry on Tuesday said that an 85 per cent decline in daily&nbsp;Covid-19&nbsp;cases has been noted since the highest reported peak on May 7. Lav Agarwal, Joint Secretary, Health Ministry said during a briefing on the Covid-19 situation said that India is&nbsp;witnessing this situation after 75 days, thus indicating an overall decline in infection rate. He also said that there are 20 states and UTs where active Covid cases are less than 5,000 in the country.

Covid-19 vaccine maker Bharat Biotech said on Tuesday that the supply price of Covaxin to the Central government at Rs 150 per dose is not sustainable in

Covid-19 vaccine maker&nbsp;Bharat Biotech&nbsp;said on Tuesday that&nbsp;the supply price of Covaxin to the Central government at Rs 150 per dose is not sustainable in the long run.
The Hyderabad-based firm said&nbsp;a higher price in private markets is required to offset part of the costs.
The Centre's supplying price is pushing the pricing structure for the private sector upward, the firm said.
Fundamental business reasons ranging from low procurement volumes, high distribution costs and retail margins, among few others, contribute to higher pricing of Covaxin to the private sector, Bharat Biotech said.
The firm is currently supplying Covaxin at Rs 150 per dose to the Centre, Rs 400 to the state government and Rs 1,200 to private hospitals.

Sitting at home during the lockdown, many used dating apps to virtually meet potential matches, but this 20-year-old girl along with her friends decided to us

Sitting at home during the lockdown, many used dating&nbsp;apps&nbsp;to virtually meet potential matches, but this 20-year-old girl along with her friends decided to use dating apps&nbsp;to actually reach out and help those in need.
The second wave of the Covid-19 pandemic crippled the health infrastructure system of the country, and in these trying times, it has been difficult to get blood donors too. Moreover, matters got further complicated as many were recovering from the infection or who just got vaccinated.&nbsp;To help hospitals and patients source blood for emergency operations, Riya&nbsp;Gupta along with a group of Chennai-based medical students decided to help connect patients with blood donors.&nbsp;
Their initiative, a blood donation drive called the Blood Donor Connect, has helped arrange blood for several people through social media platforms, including popular dating apps Tinder and Bumble.&nbsp;The team has a set database which is being constantly developed and they make over 500 calls a day to cross-check and verify the sources, the requests and donors.
Within a week of launching the blood donation drive, the team managed to find over a hundred donors.

The government has confirmed first death following coronavirus vaccination in India. The panel studying vaccine side-effects has confirmed the death of a 68-year-old ma

The government has confirmed first death following coronavirus vaccination in India. The panel studying vaccine side-effects has confirmed the death of a 68-year-old man due to anaphylaxis after taking the vaccine. The expert panel's report showed that the deceased received his first vaccine and died on March 8.
While three more deaths were found to be vaccine-related, the government panel has only confirmed the death of one person
The panel report said that vaccine product-related reactions are expected and can be attributed to vaccination based on current scientific evidence. Allergic reactions and anaphylaxis are some examples of reactions, the report added.
&nbsp;

The Indian Institute of Technology (IIT) Ropar has developed a device that can be used as a substitute for Continuous Positive Airway Pressure or CPAP machine. Dub

The Indian Institute of Technology (IIT) Ropar has developed a device that can be used as a substitute for Continuous Positive Airway Pressure or CPAP&nbsp;machine. Dubbed as "Jivan Vayu", the machine can deliver high flow oxygen up to 60 litres Per Minute (LPM).
Usually, CPAP machines use mild air pressure to keep airways open and are used for patients suffering from breathing problems and sleep apnea. The CPAP therapy helps in ensuring that the airways do not collapse while you breathe during sleep. The therapy is also used to treat infants whose lungs have not fully developed.
The new device is the "first to be designed in India that functions even without electricity" and is adapted to both kinds of oxygen generation units like CO2 cylinders and oxygen pipelines.

Amid growing traction for the theory that Covid-19 virus may have leaked from a Wuhan lab, China top bat coronavirus researcher has spoke up and has slammed the hypothe

Amid growing traction for the theory that Covid-19 virus may have leaked from a Wuhan lab, China top bat coronavirus researcher has spoke up and has slammed the hypothesis.
Known as China's 'bat woman' Shi Zhengli, who is a researcher at Wuhan Institute of Virology, has told New York Times that there is no evidence to show that the virus escaped from her lab. She has also lamented the "filth being poured on an innocent scientist".
&ldquo;How on earth can I offer up evidence for something where there is no evidence?&rdquo; she told the New York Times in rare comment to the media on the issue.
In a March 2020 article in Scientific American, Shi said that the genetic code of the virus that causes Covid-19 doesn&rsquo;t match any of her lab&rsquo;s samples.
There have been growing calls to probe deeper the possibility of virus lab leak and calls for greater transparency and aooperation from Beijing.
&nbsp;

Antibodies and immunity among people who contract Covid-19 remains from six months to a year, and get even better protection when vaccinated, according to a study publi

Antibodies and immunity among people who contract Covid-19 remains from six months to a year, and get even better protection when vaccinated, according to a study published on Monday.
The researchers followed up with 63 people 1.3 months, 6 months and 12 months after they got infected. Of these, 41% received one dose of either the Pfizer-BioNTech or the Moderna vaccine.
The study published in Nature also found the body&rsquo;s defences to have evolved over time to offer protection from mutations. The study is among the first concrete clues that immunity to the Sars-Cov-2 may be long-lasting.

A probe by the Uttarakhand health department has found that at least 1 lakh Covid test reports issued during the Kumbh Mela were fake.

A probe by the Uttarakhand health department has found that at least 1 lakh <a href="https://www.editorji.com/covid-19" target="_blank">Covid-19</a> test reports issued during the Kumbh Mela were fake. The Times of India, which has accessed the 1,600 page report, has reported that the test reports were forged by a private agency.
In one instance, a single phone number was used to register over 50 people while one antigen test kit, which is meant for single use, was shown to have tested 700 samples, the report said.
Also Read | <a href="https://www.editorji.com/story/china-s-bat-woman-speaks-up-slams-virus-lab-leak-theory-1623741150500" target="_blank">Sputnik V likely to be available in Delhi from today: report</a>
Covid negative reports were issued under fictional names and addresses. Almost 530 samples were taken from &lsquo;House Number 5&rsquo; in Haridwar, the TOI report has quoted an an official as saying.
Further, 200 sample collectors employed by the private agency turned out to be students in Rajasthan who never visited Haridwar during the period, the report added. Officials have said that two labs are also under the scanner for the fraud.
Also Read | <a href="https://www.editorji.com/story/60-000-cases-in-24-hours-lowest-in-75-days-deaths-also-down-1623733021038" target="_blank">60,000 cases in 24 hours, lowest in 75 days, deaths also down</a>

Coronavirus Update: Continuing with a downward trend, India saw a sharp decline in daily Covid-19 cases on Tuesday. 60,471 cases reported in the last 24 hours...

Continuing with a downward trend, India saw a sharp decline in daily <a href="https://www.editorji.com/covid-19" target="_blank">Covid-19 cases</a> on Tuesday. 60,471 cases reported in the last 24 hours is the lowest daily spike in 75 days. This is for the eighth successive day that the country has seen less than 100,000 fresh infections in a day.
Daily Covid deaths, which were hovering around 4,000, have also seen a dip. India logged 2,726 deaths due the virus in the last 24 hours, according to the health ministry dashboard on Tuesday morning. Total deaths due to the contagion now stand at 3.77 lakh.
The number of active Corona cases has come down to just over 9 lakh. This is the 33rd day straight where the daily recoveries continued to outnumber the new cases.
The recovery rate has climbed up to 95.64%, and positivity rate currently stands at a low of 4.39%.
Also Read | <a href="https://www.editorji.com/story/1-lakh-covid-19-tests-during-kumbh-mela-fake-finds-govt-probe-1623734230184" target="_blank">1 lakh Covid-19 tests during Kumbh mela fake, finds govt probe</a>

A Delhi government panel has recommended that parents of Covid-19 positive children, undergoing treatment in hospitals, could be allowed to enter the coronavirus ward..

A Delhi government panel has recommended that parents of <a href="https://www.editorji.com/covid-19" target="_blank">Covid-19</a> positive children, undergoing treatment in hospitals, could be allowed to enter the coronavirus ward, Live Hindustan has reported.&nbsp;
The committee has, however, said that parents would be allowed to enter the ward only in full PPE kits.
The recommendation has come in the wake of fears over a likely third wave of Covid-19 that may impact children.&nbsp;
The panel has said that parents may be allowed to meet kids if it becomes difficult to handle them in the hospitals, the report said.&nbsp;
The panel has also suggested that health workers need to be trained to look after children admitted to intensive care units.
Also Read | <a href="https://www.editorji.com/story/60-000-cases-in-24-hours-lowest-in-75-days-deaths-also-down-1623733021038" target="_blank">60,000 Covid cases in 24 hours, lowest in 75 days, deaths also down</a>

Vaccines from Pfizer and AstraZeneca Plc protect against Delta variant of Covid-19 that was first detected in India, researchers said on Monday. They found the shot mad

Vaccines from Pfizer and AstraZeneca Plc protect against Delta variant of Covid-19 that was first detected in India, researchers said on Monday. They found the shot made by Pfizer offered better protection in a large study from Scotland.
Researchers from the Universities of Edinburgh and Strathclyde, as well as Public Health Scotland, found that the Pfizer vaccine offered 92% protection against the alpha variant, found in UK last year, and 79% against the delta one 14 days after the second dose. That compared with 73% and 60% protection for the Astra vaccine.
Researchers said a more complete analysis from these results would be made once it was combined with similar studies from the U.K. and elsewhere.

The Russian vaccine against Covid-19, Sputnik V, is likely to be available at Indraprastha Apollo Hospital in Delhi from Tuesday, according to a report. The Sputnik V r

The Russian vaccine against Covid-19, Sputnik V, is likely to be available at Indraprastha Apollo Hospital in Delhi from Tuesday, according to a report. The Sputnik V rollout will depend on the number of consignments received by the hospital, news agency ANI has reported.
The Centre has fixed the price of the vaccine at ₹1,145 per dose.
ANI also reported that Sputnik V was administered to employees of Dr Reddy's Laboratories at Delhi's Indraprastha Apollo Hospital on Sunday. As many as 1000 doses of Sputnik V reached the Apollo Hospital and 179 doses were administered to the Dr Reddy's Laboratories&rsquo; employees.
Dr Reddy's Laboratories has partnered with the Russian Direct Investment Fund, which globally markets the Covid-19 vaccine, for the rollout of the two-dose vaccine in India.
Sputnik V claimed to have the highest efficacy rate at 91.6 per cent&mdash;Moderna and Pfizer vaccines also have an efficacy of over 90 per cent.

explore newslists

Covid-19

Covid vaccine scam: Mumbai housing society residents suspect fake shots given

Decision to extend Covishield dose gap based on science: health minister

62k new Covid cases, 2,500 deaths in 24 hrs, active cases under 9 lakh

Rethink in India as UK slashes Covid vaccine gap: report

CBSE may opt for 30:30:40 formula for class XII grades: report

Walk-in Covid vaccination now open to all adults: govt

Covid-19: Delta plus 'variant of interest' not 'variant of concern', says Centre

Covid-19: not all post-vaccination deaths linked to jabs, says Centre

Centre: nearly 85% decline in daily Covid-19 cases since highest peak

₹150 per Covaxin dose not sustainable in long run: Bharat Biotech

Chennai college students use Tinder, Instagram to start a blood-donation drive

Govt panel confirms first death after Covid-19 vaccination in India

IIT Ropar develops electricity free CPAP device 'Jivan Vayu', first in India

China's 'bat woman' speaks up, slams virus lab leak theory

Immunity lasts at least a year after Covid, gets stronger after vaccine: study

1 lakh Covid-19 tests during Kumbh mela fake, finds govt probe

60,000 Covid cases in 24 hours, lowest in 75 days, deaths also down

Parents of admitted Covid +ve kids may be allowed inside wards

Pfizer, AstraZeneca vaccines protect against Delta variant: study

Sputnik V likely to be available in Delhi from today: report

follow editorji

download editorji